Program Overview
IECC 2024 Program
Click here to register for IECC 2024 for free! The registration includes attendance to all conference sessions.
6 March 2024 (Wednesday)
Session G. Cancer Therapy
Session G. Cancer Therapy
| CET (Central European Time - UTC+1) |
CST Asia (China Standard Time - UTC+8) |
Speaker | Title |
| 9:00-9:15 | 16:00-16:15 | Welcome from the conference chair- Dr. Shinji Kawabata and the session chair-Dr. Ulrich Pfeffer | |
| 9:15-9:35 | 16:15-16:35 | Invited Speaker Michela Croce |
Epigenetic drugs to improve efficacy of immune checkpoint blocker therapy |
| 9:35-9:55 | 16:35-16:55 |
Invited Speaker |
Targeting chromatin remodelers to overcome endocrine therapy resistance in breast cancer |
| 9:55-10:10 | 16:55-17:10 | Selected Speaker Yoshiki Fujikawa |
Exploring BNCT as a Novel Approach for Metastatic Spinal Tumor Management |
| 10:10-10:25 | 17:10-17:25 |
Selected Speaker |
Evaluation of the safety of folate receptor-targeted boron carrier in boron neutron capture therapy (BNCT) for malignant gliomas using CED administration |
6 March 2024 (Wednesday)
Session H. Cancer Pathophysiology
Session H. Cancer Pathophysiology
| CET (Central European Time - UTC+1) |
CST Asia (China Standard Time - UTC+8) |
Speaker | Title |
| 15:00-15:10 | 22:00-22:10 | Welcome from session chairs - Prof. Nicola Amodio and Prof. Giuseppe Viglietto | |
| 15:10-15:30 | 22:10-22:30 | Invited Speaker Annamaria Gullà |
Dissecting the path to immunogenic chemotherapy in multiple myeloma |
| 15:30-15:50 | 22:30-22:50 | Invited Speaker Bruno Simoes |
Targeting cancer stem cells in hormone-resistant breast cancer |
| 15:50-16:10 | 22:50-23:10 | Invited Speaker Giuseppina Augimeri |
A hybrid cell population generated through engulfment of mesenchymal stem cell by breast cancer cells enhances chemoresistance and metastasis |
| 16:10-16:20 | 23:10-23:20 | Break | |
| 16:20-16:40 | 23:20-23:40 | Invited Speaker Marilena V Iorio |
ncRNA deregulation as a flag of drug resistance in HER2-positive breast cancer |
| 16:40-17:00 | 23:40-00:00 | Invited Speaker Cirino Botta |
The Dynamic myeloma microenvironment: implications for cancer evolution and therapy resistance |
| 17:00-17:20 | 00:00-00:20 | Invited Speaker Zachary R. Hunter |
Multi-omic Analysis of Clonal Evolution and the Subtypes of Waldenstrom's Macroglobulinemia |
| 17:20-17:35 | 00:20-00:35 |
Selected Speaker |
Deciphering the role of USP16 in lung cancer |
7 March 2024 (Thursday)
Session C. Cancer Immunology and Immunotherapy
Session C. Cancer Immunology and Immunotherapy
| CET (Central European Time - UTC+1) |
CST Asia (China Standard Time - UTC+8) |
Speaker | Title |
| 8:00-8:05 | 15:00-15:05 | Welcome from session chair - Prof. Dr. Vasso Apostolopoulos | |
| 8:05-8:25 | 15:05-15:25 | Keynote Speaker Magdalena Plebanski |
Personalised immunotherapy and earlier diagnosis in ovarian cancer |
| 8:25-8:40 | 15:25-15:40 | Invited Speaker John Trant |
Cancer Immunotherapy three ways |
| 8:40-8:55 | 15:40-15:55 | Invited Speaker Rajamaran Eri |
ROLE OF NLRP3 INFLAMMASOME COLITIS-ASSOCIATED COLORECTAL CANCER |
| 8:55-9:10 | 15:55-16:10 | Selected Speaker Nyanbol Kuol |
Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines |
| 9:10-9:20 | 16:10-16:20 | Break | |
| 9:20-9:35 | 16:20-16:35 | Invited Speaker Andreas Tzakos |
Targeting Gliomas |
| 9:35-9:50 | 16:35-16:50 | Invited Speaker George Alexiou |
NEW THERAGNOSTIC AGENT AGAINST GLIOMA BASED ON GEMCITABINE |
| 9:50-10:05 | 16:50-17:05 | Invited Speaker Vivek Chavda |
CAR T‑Cell therapy for the management of mantle cell lymphoma |
| 10:05-10:20 | 17:05-17:20 |
Selected Speaker |
Differential Gene Expression of Checkpoint Markers and Cancer Markers in Mouse Models of Spontaneous Chronic Colitis |
7 March 2024 (Thursday)
Session B. Cancer Biomarkers
Session B. Cancer Biomarkers
| CET (Central European Time - UTC+1) |
CST Asia (China Standard Time - UTC+8) |
Speaker | Title |
| 15:00-15:05 | 22:00-22:10 | Welcome from session chair - Prof. Dr. Mario Capasso |
|
| 15:05-15:25 | 22:05-22:25 | Invited Speaker Ramin Massoumi |
Unlocking the Future of Lung Cancer Treatment: Biomarkers and Preclinical Insights |
| 15:25-15:40 | 22:25-22:40 | Selected Speaker Ella Markalunas |
Correlational Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients |
| 15:40-15:55 | 22:40-22:55 | Selected Speaker Alejandro Cepero |
Predictive Value of FDG PET Radiomics for Early Response to Chemoradiation in Locally Advanced Cervical Cancer |
| 15:55-16:05 | 22:55-23:05 | Break | |
| 16:05-16:20 | 23:05-23:20 | Invited Speaker Schleiermacher Gudrun |
Predictive biomarkers in pediatric oncology - the role of clonal evolution studied by sequential cfDNA |
| 16:20-16:40 | 23:20-23:40 | Invited Speaker Banafshé Larijani |
The fusion of quantitative molecular proteomics and immune-oncology: a step towards precision medicine in cancer therapeutic. |
| 16:40-16:45 | 23:40-23:45 |
Session Chair |
Closing Speech |
The list of names and titles are the posters can be found here.
| CET (Central European Time - UTC+1) |
CST Asia (China Standard Time - UTC+8) |
Speaker | Title |
| 9:00 - 11:00 | 16:00 - 18:00 | Poster Session | The Poster Session will take place in Zoom breakout rooms. |
8 March 2024 (Friday)
Session D. Tumor Microenvironment
Session D. Tumor Microenvironment
Session E. Molecular Cancer Biology
Session F. Cancer Epidemiology and Prevention
| CET (Central European Time - UTC+1) |
CST Asia (China Standard Time - UTC+8) |
Speaker | Title |
| 15:00-15:05 | 22:00-22:10 | Welcome from session chair - Prof. Dr. Robert-Alain Toillon | |
| 15:05-15:25 | 22:05-22:25 | Invited Speaker Prof. Dr. Robert-Alain Toillon |
Microenvironment and Breast Cancer |
| 15:25-15:40 | 22:25-22:40 | Selected Speaker Kamila Wolnica |
Infrared molecular responce of craniofacial squamous cell carcinoma - pilot study |
| 15:40-15:55 | 22:40-22:55 | Selected Speaker Vincenzo Aievola |
Noncoding regulatory mutations as a driving event for the oncogenic core regulatory circuitries of neuroblastoma |
| 15:55-16:10 | 22:55-23:10 | Selected Speaker Teresa Maiorino |
Post-GWAS functional analysis of the 11p11.2 risk locus identifies HSD17B12 as a neuroblastoma susceptibility gene involved in lipid metabolism |
| 16:10-16:25 | 23:10-23:25 |
Selected Speaker |
Polycyclic aromatic hydrocarbons (PAHs) in grilled marshmallows |
| 16:25-16:40 | 23:25-23:40 |
Selected Speaker |
Suppression of Medulloblastoma Cell Migration by clinically Significant Doses of Simvastatin through Mevalonate Pathway Targeting |
| 16:40-16:55 | 23:40-23:55 |
Selected Speaker |
Exposure to mycovirus-containing Aspergillus flavus alters transcription factors in normal and leukemia cell lines |